ID   G-361/CMV-Luc#2(c-2.5)
AC   CVCL_JG86
DR   cancercelllines; CVCL_JG86
DR   JCRB; JCRB1687
DR   JCRB; NIHS1040
DR   Wikidata; Q54835346
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1040; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): JCRB=JCRB1687
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1220 ! G-361
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 13
//